Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0545120120220040535
Journal of Microbiology and Biotechnology
2012 Volume.22 No. 4 p.535 ~ p.540
Cloning and Characterization of Ginsenoside Ra1-Hydrolyzing ¥â-D-Xylosidase from Bifidobacterium breve K-110
Hyun Yang-Jin

Kim Dong-Hyun
Abstract
¥â-D-Xylosidase (E.C. 3.2.1.37) from Bifidobacterium breve K-110, which hydrolyzes ginsenoside Ra1 to ginsenoside Rb2, was cloned and expressed in Escherichia coli. The (His6)-tagged recombinant enzyme, designated as XlyBK- 110, was efficiently purified using Ni2+-affinity chromatography (109.9-fold, 84% yield). The molecular mass of XylBK- 100 was found to be 55.7 kDa by SDS-PAGE. Its sequence revealed a 1,347 bp open reading frame (ORF) encoding a protein containing 448 amino acids, which showed 82% identity (DNA) to the previously reported glycosyl hydrolase family 30 of Bifidobacterium adolescentis ATCC 15703. The Km and Vmax values toward p-nitrophenyl-¥â-D-xylopyranoside (pNPX) were 1.45mM and 10.75 ¥ìmol/min/mg, respectively. This enzyme had pH and temperature optima at 6.0 and 45oC, respectively. XylBK-110 acted to the greatest extent on xyloglucosyl kakkalide, followed by pNPX and ginsenoside Ra1, but did not act on p-nitrophenyl-¥á-Larabinofuranoside, p-nitrophenyl-¥â-D-glucopyranoside, or p-nitrophenyl-¥â-D-fucopyranoside. In conclusion, this is the first report on the cloning and expression of ¥â-Dxylosidase- hydrolyzing ginsenoside Ra1 and kakkalide from human intestinal microflora.
KEYWORD
Recombinant ¥â-D-xylosidase, Bifidobacterium breve K-110, ginsenoside Ra1, kakkalide
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)